These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 14707778)

  • 1. Measuring performance during the menstrual cycle: a model using oral contraceptives.
    Redman LM; Weatherby RP
    Med Sci Sports Exerc; 2004 Jan; 36(1):130-6. PubMed ID: 14707778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the phase of the menstrual cycle and the birth control pill on athletic performance.
    Lebrun CM
    Clin Sports Med; 1994 Apr; 13(2):419-41. PubMed ID: 8013042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
    Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
    Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of menstrual cycle phase and oral contraceptive use on intermittent exercise.
    Lynch NJ; Nimmo MA
    Eur J Appl Physiol Occup Physiol; 1998 Nov; 78(6):565-72. PubMed ID: 9840414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the menstrual cycle on performance of intermittent, high-intensity shuttle running in a hot environment.
    Sunderland C; Nevill M
    Eur J Appl Physiol; 2003 Jan; 88(4-5):345-52. PubMed ID: 12527962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptive phase has no effect on endurance test.
    Rechichi C; Dawson B; Goodman C
    Int J Sports Med; 2008 Apr; 29(4):277-81. PubMed ID: 17990209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menstrual cycle phase and oral contraceptive effects on triglyceride mobilization during exercise.
    Casazza GA; Jacobs KA; Suh SH; Miller BF; Horning MA; Brooks GA
    J Appl Physiol (1985); 2004 Jul; 97(1):302-9. PubMed ID: 14990561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of menstrual cycle phase and oral contraceptive use on verbal memory.
    Mordecai KL; Rubin LH; Maki PM
    Horm Behav; 2008 Aug; 54(2):286-93. PubMed ID: 18455727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No effect of menstrual cycle phase and oral contraceptive use on endurance performance in rowers.
    Vaiksaar S; Jürimäe J; Mäestu J; Purge P; Kalytka S; Shakhlina L; Jürimäe T
    J Strength Cond Res; 2011 Jun; 25(6):1571-8. PubMed ID: 21399539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term response of bone turnover to low-dose oral contraceptives in exercising women with hypothalamic amenorrhea.
    Vescovi JD; VanHeest JL; De Souza MJ
    Contraception; 2008 Feb; 77(2):97-104. PubMed ID: 18226672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial microstructure after long-term use of a 91-day extended-cycle oral contraceptive regimen.
    Anderson FD; Hait H; Hsiu J; Thompson-Graves AL; Wilborn WH; Williams RF
    Contraception; 2005 Jan; 71(1):55-9. PubMed ID: 15639074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemodynamics and ergometric performance modified by low dosage oral contraceptives].
    Hartard M; Haber P; Havelec L; Jeschke D
    Zentralbl Gynakol; 1996; 118(1):37-41. PubMed ID: 8588450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral contraceptives on hormonal and metabolic responses during exercise.
    Bemben DA; Boileau RA; Bahr JM; Nelson RA; Misner JE
    Med Sci Sports Exerc; 1992 Apr; 24(4):434-41. PubMed ID: 1560739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age at first oral contraceptive use as a major determinant of vertebral bone mass in female endurance athletes.
    Hartard M; Kleinmond C; Kirchbichler A; Jeschke D; Wiseman M; Weissenbacher ER; Felsenberg D; Erben RG
    Bone; 2004 Oct; 35(4):836-41. PubMed ID: 15454090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
    Griffith SG; Dai Y
    Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial.
    Davis AR; Westhoff C; O'Connell K; Gallagher N
    Obstet Gynecol; 2005 Jul; 106(1):97-104. PubMed ID: 15994623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse).
    Barbosa IC; Filho CI; Faggion D; Baracat EC
    Contraception; 2006 Jan; 73(1):30-3. PubMed ID: 16371291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for new oral contraceptive dosing.
    Williams JK
    Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of menstrual cycle phase on athletic performance.
    Lebrun CM; McKenzie DC; Prior JC; Taunton JE
    Med Sci Sports Exerc; 1995 Mar; 27(3):437-44. PubMed ID: 7752873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.